ObsEva SA to Participate in Cantor Global Healthcare Conference October 2-4, 2019
Geneva, Switzerland and Boston, MA – September 27, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced that Company Management will be participating in the Cantor Global Healthcare Conference taking place October 2-4, 2019 in New York City. ObsEva will present on Friday, October 4 at 7:45 a.m. Eastern time (ET).
The presentation webcast will be available in the “Investors” section of ObsEva’s website www.ObsEva.com.
About ObsEva
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving IVF outcomes. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.
For further information, please contact:
Media Contact Switzerland and Europe:
Christophe Lamps Dynamics Group
cla@dynamicsgroup.ch
+41 22 308 6220 Office
+41 79 476 26 87 Mobile
Media Contact U.S.:
Marion Janic RooneyPartners LLC
mjanic@rooneyco.com
+1 212 223 4017 Office
+1 646 537 5649 Mobile
CEO Office Contact:
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550
Investor Contact:
Mario Corso
Senior Director, Investor Relations
mario.corso@obseva.com
+1 857 972 9347 Office
+1 781 366 5726 Mobile
##
Attachment
About GlobeNewswire
GlobeNewswireGlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Cypress Development Files Prefeasibility Study for Clayton Valley Lithium Project in Nevada3.6.2020 21:13:48 CEST | Press release
VANCOUVER, British Columbia, June 03, 2020 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCQB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or “the Company”) is pleased to announce, further to its News Release on May 19, 2020, the full Prefeasibility Study (PFS) of the Clayton Valley Lithium Project in Nevada, U.S.A. was filed on SEDAR and is available on the Company’s web site. The PFS was prepared by Continental Metallurgical Services (CMS) and Global Resource Engineering (GRE) and has an Effective Date of May 19, 2020. Todd Fayram (CMS), Terre Lane (GRE), and Daniel Kalmbach are the authors. Highlights from the PFS and news release are as follows: Average production rate of 15,000 tonnes per day to produce 27,400 tonnes lithium carbonate equivalent (LCE) annually over a +40-year mine life. Capital cost estimate of US$493 million, pre-production, and operating cost estimate averaging US$3,329* per tonne LCE. (* see Note) After-tax net present value at an 8% discount rate (NPV-8%)
Cleantech Building Materials: Notice of AGM3.6.2020 18:55:17 CEST | Press release
3 June 2020 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM CLEANTECH BUILDING MATERIALS PLC Notice of AGM Cleantech Building Materials plc ("CBM" or the "Company") confirms that the Annual General Meeting will be held on 26 June 2020 at 11.00am at 19 Colville Mews, London, W11 2DA. Copies of the following documents have today been posted to the Company’s shareholders: 1. Circular to shareholders of the Company, including notice of the Annual General Meeting of the Company; 2. Form of proxy for use at the Annual General Meeting; and 3. Annual Results of the Company for the year ended 31 December 2019. A copy of the Circular and the Form of Proxy are attached to this release. Further information including the Circular, the Form of Proxy and the Annual Results may be found at the Company's website at www.cbm-plc.com COVID-19 – AGM Arrangements Due to the ongoing UK Government "stay at home measures" which currently include a prevention of public
Arion Bank: Covered bond offering results3.6.2020 18:53:06 CEST | Press release
Today Arion Bank hf. concluded the sale of two covered bond series. In total, 24 bids were received in the auction for the amount of ISK 2,980 million. The inflation-linked series ARION CBI 26 attracted 17 bids of ISK 2,400 million at a yield of 0.62-0.70%. Bids for nominal amount of ISK 1,000 million at a yield of 0.65% were accepted. The size of the series following the issuance will be ISK 17,080 m. The fixed rate series ARION CB 24 attracted 7 bids of ISK 580 million at a yield of 2.54–2.58%. All bids were rejected at this time. The issued bonds are scheduled to be admitted to trading on Nasdaq Iceland on 10 June 2020. For further information please contact Investor relations, at ir@arionbanki.is
Medtronic CEO Geoff Martha to Speak at Goldman Sachs Global Healthcare Conference3.6.2020 17:00:10 CEST | Press release
DUBLIN, June 03, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 41st Annual Global Healthcare Conference, held virtually on Tuesday, June 9, 2020. Geoff Martha, Medtronic chief executive officer, will answer questions about the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT). A live audio webcast of the session will be available on June 9, 2020, by clicking on the Investor Events link at http://investorrelations.medtronic.com, and an archive of the session will be available on the same webpage later in the day. About Medtronic Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than
Resolutions by Vaisala Corporation Annual General Meeting and the Board of Directors3.6.2020 16:30:00 CEST | Press release
Vaisala Corporation Stock exchange release June 3, 2020 at 5:30 p.m. (EEST) Resolutions by Vaisala Corporation Annual General Meeting and the Board of Directors Vaisala Corporation’s Annual General Meeting was held on June 3, 2020. The meeting approved the financial statements and discharged the members of the Board of Directors and the President and CEO from liability for the financial period January 1–December 31, 2019. Dividend The Annual General Meeting decided a dividend of EUR 0.61 per share. The record date for the dividend payment is June 5, 2020, and the payment date is June 12, 2020. Board of Directors The Annual General Meeting confirmed that the number of Board members is eight. Petri Castrén, Petra Lundström, Jukka Rinnevaara, Kaarina Ståhlberg, Tuomas Syrjänen, Raimo Voipio and Ville Voipio will continue as members of the Board of Directors. Antti Jääskeläinen was elected as a new member of the Board of Directors. The Annual General Meeting confirmed that that the annual
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING3.6.2020 16:20:00 CEST | Press release
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING 2020-06-05 Transaction type:SEK CreditTender date:2020-06-05Time for submission of bids:10.00-10.30 (CEST)Payment date:2020-06-09Final repayment date2022-06-09Offered volume:50 bn SEKMinimum bid amount:10 mln SEKMaximum bid amount:12.5 bn SEKMaximum number of bids from each participant: 1Interest rate:0.00 %Supplemental interest rate 0.20 percentage points ALL APPROVED COUNTERPARTIES ARE INVITED TO SUBMIT VOLUME BIDS TO THE RIKSBANK (46-8-6966970) BY 10.30 ON JUNE 5 2020, AT THE LATEST. Result of the auction will be published at 11.00 (CEST) on Tender date. Complete terms and conditions can be retrieved at http://www.riksbank.se